9 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... Chronic Obstructive Lung ... β2-agonist; ICS ... #Management #Pulmonary ... #COPD #GOLD2017
Multifocal Atrial Tachycardia (MAT)
• At least 3 different P wave morphologies: 
• Rate 100-180
• Irregular 
Etiology
Secondary to chronic lung ... disease (COPD) ... • Hypoxia • Pulmonary ... • Oxygen • Treatment ... MAT #Cardiology #Diagnosis
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
First-line therapies ... The diagnosis ... overlap; ICS = ... #Diagnosis #Management ... Differences #Algorithm #Treatment
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
disease (COPD) ... #COPD #Treatment ... #Algorithm #Management ... LAMA #SABA #SAMA #ICS ... #Pharmacology
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
pattern, irregular lines ... Organizing Pneumonia Treatment ... #BOOP #pulmonary ... #ILD #diagnosis ... #management
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
multiplex WORKUP & DIAGNOSIS ... sparing of the lung ... blood retum in serial ... #differential #diagnosis ... #management #treatment
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
importantly, bedside ultrasound ... with presence of pulmonary ... edema (“B-lines ... #algorithm #management ... #clinical #pharmacology
Fluid Responsiveness and Fluid Tolerance Testing - OnePager Summary
Fluid resuscitation can be beneficial when required or
Arterial Line: ... Pulmonary Artery ... Point of Care Ultrasound ... Tolerance #testing #diagnosis ... comparison #challenges #management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... #Management